This observational study aims to recruit females, aged 16 years and over, with phenylketonuria (PKU) or hyperphenylalaninemia (hyperphe) following dietary management advice pre-conception and/or during pregnancy, who are willing to take PKU sphere as part of their dietarty management.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Change in blood spot phenylalanine levels
Timeframe: Baseline, 1-2 times weekly during preconception (max. 2 years), 2-3 times weekly during pregnancy, one month postpartum.
Change in blood spot tyrosine levels
Timeframe: Baseline, 1-2 times weekly during preconception (max. 2 years), 2-3 times weekly during pregnancy, one month postpartum.
Change in adherence to study product intake
Timeframe: Every 12 weeks from baseline during preconception (max. 2 years) and pregnancy until the end of the pregnancy
Participants' gastrointestinal adverse events
Timeframe: Throughout the study until one month postpartum
Change in weight
Timeframe: Baseline, every 24 weeks during preconception (max. 2 years) and pregnancy, one month postpartum
Change in plasma amino acid profile
Timeframe: Baseline, all routine results during preconception (max. 2 years) and pregnancy, one month postpartum
Change in plasma micronutrient profile
Timeframe: Baseline, all routine results during preconception (max. 2 years) and pregnancy, one month postpartum
Pregnancy outcome
Timeframe: End of pregnancy